Engineering synthetic antibody binders for allosteric inhibition of prolactin receptor signaling.
Rizk, S.S., Kouadio, J.L., Szymborska, A., Duguid, E.M., Mukherjee, S., Zheng, J., Clevenger, C.V., Kossiakoff, A.A.(2015) Cell Commun Signal 13: 1-1
- PubMed: 25589173 
- DOI: https://doi.org/10.1186/s12964-014-0080-8
- Primary Citation of Related Structures:  
4I18 - PubMed Abstract: 
Many receptors function by binding to multiple ligands, each eliciting a distinct biological output. The extracellular domain of the human prolactin receptor (hPRL-R) uses an identical epitope to bind to both prolactin (hPRL) and growth hormone (hGH), yet little is known about how each hormone binding event triggers the appropriate response.
Organizational Affiliation: 
Department of Biochemistry and Molecular Biology, The University of Chicago, Chicago, IL, USA. srizk@nd.edu.